Bupropion: Difference between revisions
From SEHK Wiki
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
==Drug Usage== | ==Drug Usage== | ||
*Major depressive disorder (MDD) | |||
*Seasonal affective disorder (SAD): Bupropion is used to manage seasonal patterns of depression. | |||
*Smoking cessation: Under the brand name Zyban, it helps reduce nicotine cravings and withdrawal symptoms. | |||
==Mechanism of Action== | |||
Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI). | |||
It works by inhibiting the reuptake of norepinephrine and dopamine, two neurotransmitters involved in mood regulation and reward pathways. By preventing their reabsorption, bupropion increases the levels of these neurotransmitters in the brain, which can help alleviate symptoms of depression and aid in smoking cessation. | |||
==Route of Administration== | |||
Oral | |||
==Dosages== | |||
Major depressive disorder (MDD): | |||
*Immediate-release: 100 mg twice daily, up to 450 mg/day | |||
*Sustained-release: 150 mg twice daily, up to 400 mg/day | |||
*Extended-release: 150 - 300 mg once daily, up to 450 mg/day | |||
Renal dose based on eGFR: | |||
*eGFR 30 - 89 mL/min: Reduce dose by 25 - 50% | |||
*eGFR <30 mL/min: Reduce dose by 50% or more | |||
==Side Effects== | |||
Revision as of 02:42, 15 August 2024
Drug class: Atypical Antidepressants
Bupropion (WELLBUTRIN)(中文:安非他酮)
Common Strengths of Bupropion
Bupropion are available in the following strengths:
- Immediate-release: 75 mg, 100 mg
- Sustained-release (SR): 100 mg, 150 mg, 200 mg
- Extended-release (XL): 150 mg, 300 mg, 450 mg
Drug Trade Names of Bupropion
- Wellbutrin
- Wellbutrin SR
- Wellbutrin XL
- Zyban
Drug Usage
- Major depressive disorder (MDD)
- Seasonal affective disorder (SAD): Bupropion is used to manage seasonal patterns of depression.
- Smoking cessation: Under the brand name Zyban, it helps reduce nicotine cravings and withdrawal symptoms.
Mechanism of Action
Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI). It works by inhibiting the reuptake of norepinephrine and dopamine, two neurotransmitters involved in mood regulation and reward pathways. By preventing their reabsorption, bupropion increases the levels of these neurotransmitters in the brain, which can help alleviate symptoms of depression and aid in smoking cessation.
Route of Administration
Oral
Dosages
Major depressive disorder (MDD):
- Immediate-release: 100 mg twice daily, up to 450 mg/day
- Sustained-release: 150 mg twice daily, up to 400 mg/day
- Extended-release: 150 - 300 mg once daily, up to 450 mg/day
Renal dose based on eGFR:
- eGFR 30 - 89 mL/min: Reduce dose by 25 - 50%
- eGFR <30 mL/min: Reduce dose by 50% or more
